Innovating Works
MetaTox-HS: Advanced Solutions for High Sensitivity Metabolism and Toxicity Assays LUXCEL BIOSCIENCES LTD tramitó un H2020: H2020-SMEInst-2016-2017 "Drug failure and high development cost (est. €2.3bn/new drug) has driven enormous growth in market need for scientific tests and models of...
2017-07-04 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.